BioSpace News Archive

- SciBase (SCIB) Stockholm, Sweden - announced today that it has received approval from the US Food and Drug Administration (FDA) for Nevisense 3.0, the third generation of their Nevisense system for early melanoma detection. Nevisense, an AI-based point-of-care system for the non-invasive evaluation of irregular moles remains the only FDA ap

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that, due to public health and safety concerns related to the coronavirus (“COVID-19") pandemic, recommendations and orders from federal, state and local authorities, and to support the health and well-being of its stockholders, employees, and others, it will host it

Idera Pharmaceuticals, Inc. (“Idera” or the “Company”) (Nasdaq: IDRA) today provided notice of a change in the location for its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) via the filing of additional proxy materials with the U.S. Securities and Exchange Commission. Due to the public health impact of the coronavirus (COVID-19) pandemic and related government actions, and to support the health and well-being of our employees, stockho

Centene Corporation (NYSE: CNC) announced today it will present in a virtual format at the BofA Securities 2020 Health Care Conference, to be held from May 12-14, 2020 . Centene will present on Wednesday, May 13, 2020 , at 9:40 a.m. Eastern Daylight Time (EDT). A simultaneous live audio webcast is available at: http://www.veracast.com

Total Revenue of $12.1 Million Increased 110% Year-over-Year and 46% Sequentially First Quarter 2020 Conference Call Scheduled for May 14

New study identifies a type of T cells in tissues that preferentially supports latent infection by HIV

Correvio Pharma Corp. today announced that Institutional Shareholder Services Inc. (“ISS”), a leading independent proxy advisory firm, released a report (the “ISS Report”) recommending that Correvio shareholders vot

Conference Call and Webcast Scheduled for Thursday, May 7, 2020 at 8:30 AM ET

Veracyte Launches “More About You” Campaign to Educate Patients About Thyroid Cancer Diagnosis

Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2020 results after the market closes on Monday, May 11, 2020, to be followed by a conference call at 4:30 p.m. (Eastern Time).